The Adapt Oculus trial is unique in that it includes a patient population often overlooked in clinical trials, patients presenting with ocular myasthenia gravis (MG).

Dry eye has emerged as an early warning sign of autoimmune disease, appearing roughly three years before many patients receive a formal diagnosis. That gap reframes a common irritation as a potential ...

Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that ...

Taiwanese study puts numbers to common but poorly studied phenomenon ...

Stargardt programs address ABCA4 payload constraints via dual-AAV platforms (VG801, AAVB-039) and explore first ...

MONTREAL, TORONTO and VANCOUVER, BC, March 4, 2026 /CNW/ – adMare BioInnovations is proud to announce the launch of ...

Investors were looking for a greater difference between Ocular’s experimental medicine and a low-dose version of Eylea, analysts said.

Ocular surface disease (OSD) develops from a combination of adverse conditions that ultimately damage the surface layers of the eye. While the early symptoms of ocular surface disease might amount to ...

Weight loss medications Mounjaro and Zepbound, which contain the active ingredient tirzepatide, may lower the risk of diabetic retinopathy.

Frequent dry eyes may signal more than simple irritation and could be an early warning sign of an autoimmune disease. This ...

The primary applications of virtual reality in ophthalmology include physician and patient education, diagnostic testing in ...

Dry eye disease affects many people across different autoimmune diseases, ranging in prevalence from about 23% to 81%, and appears about 3 years before diagnosis, a study finds.